CMRI researchers discovered that DNA repair pathways control how cancer cells die after radiotherapy. Blocking a key repair process, homologous recombination, forces cancer cells to die in a way that ...

The new technology – Cleavage Under Targeted Accessible Chromatin (CUTAC) – focuses on small, fragmented DNA non-coding ...